Power Law company profile

Merus

Biotech & Life Sciences · Utrecht, Netherlands · Founded 2003 · IPO 2016 Unicorn

Antibody engineering to battle cancer

Valuation

$6.20B

Market cap · Jan/2026

Revenue

$36M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Investors

9 investors on Merus's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

EQT Life Sciences

Novartis Venture Fund

Series B+ 7 investors entered at this stage

Utrecht Science Park

Aglaia BioMedical Ventures

Sofinnova Partners

Bay City Capital

Johnson & Johnson Development Corporation

Novo Holdings

Pfizer

Global footprint

Where Merus has talent and traffic

AI talent share

0.8% of workforce is AI talent
(2 of 262 staff)

Core AI20.76%

Other AI00%

Non-AI workforce26099.24%

Workforce by country

9 countries with
team presence

🇳🇱 Netherlands69.3%

🇺🇸 United States23.7%

🇬🇧 United Kingdom2.7%

🇨🇭 Switzerland1.3%

🇪🇸 Spain0.9%

Top 5 of 9 shown

Web traffic by country

15K monthly visits
across markets

🇺🇸 United States37.3%

🇮🇳 India24%

🇳🇱 Netherlands11.3%

🇬🇧 United Kingdom10%

🇭🇰 Hong Kong8.7%

Top 5 markets shown

Patent intelligence

$172M patent portfolio · 102 active families

Estimated portfolio value

$172M

2.8% of market cap · 11.8× smaller than top peer Ablynx ($2B)

102 active patent families

Where Merus innovates Molecular biologyCarcinosisCancer researchAntiendomysial antibodiesBinding domain

Where Merus concentrates vs peers

Each axis is a top-10 topic across Merus and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Merus

An AI-synthesized read of the highest-engagement posts about Merus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Merus on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles